Your browser doesn't support javascript.
loading
Visual outcome, ocular findings, and visual quality of life in patients with Fabry disease.
Nilsson, Mattias; Kolagari, Hani Tavakoli; Epstein, David; Samolov, Branka; Olsson, Monica; Naess, Karin; Oscarson, Mikael; Teaer Fahnehjelm, Kristina.
Afiliação
  • Nilsson M; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Kolagari HT; Turebergs Vårdcentral, Stockholm, Sweden.
  • Epstein D; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Samolov B; Department of Vitreoretinal Diseases, St. Erik Eye Hospital, Stockholm, Sweden.
  • Olsson M; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Naess K; Department of Anterior Segment Diseases, St. Erik Eye Hospital, Stockholm, Sweden.
  • Oscarson M; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Teaer Fahnehjelm K; Department of Paediatric Ophthalmology, Strabismus and Electrophysiology. St. Erik Eye Hospital, Stockholm, Sweden.
Ophthalmic Genet ; 43(6): 841-849, 2022 12.
Article em En | MEDLINE | ID: mdl-36325813
ABSTRACT

BACKGROUND:

Fabry disease (FD) is an X-linked lysosomal disease, in which diagnosis is often established several years after onset of symptoms. Ocular manifestations can occur in childhood and be a clue to earlier diagnosis. The aim was to report ocular outcome and visual quality of life (QoL) in patients with FD. MATERIAL AND

METHODS:

FD-patients recruited from Karolinska University Hospital underwent ophthalmological examinations including best corrected visual acuity (BCVA), refraction, biomicroscopy, optical coherence tomography, keratometry, review of medical records and QoL Inventories. A total severity score (TSS), as estimated via Fabry Stabilization Index, was calculated.

RESULTS:

Twenty-six FD-patients (16 men) mean age 36.4 years (range 5.0-63.5 years) were included. BCVA was median 1.0 (range 0.5-1.6). Conjunctival blood vessel tortuosity occurred in 15/26 patients, chemosis in 2/26 patients, cornea verticillata in 23/26 patients, lens opacities in 19/26 patients, and tortuous or dilated retinal vessels in 20/25 patients. Group-wise comparisons of adult patients showed no differences regarding age, TSS, or ocular parameters. Overall, TSS was correlated to age (r = 0.53, p = 0.02). A linear regression model showed that age and sex explained 38% of the variance in TSS. Keratometry did not reveal corneal ectasia in any of the 12 patients examined. VFQ 25 in 15 patients showed a high median composite score, 93.6 (range 78.1-100).

CONCLUSIONS:

BCVA in FD-patients was good despite corneal and lens pathology. Ocular variables did not show an association with TSS in adult patients. Corneal or lens opacities should also lead to a suspicion of FD in children.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Catarata / Doença de Fabry / Doenças da Túnica Conjuntiva Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Catarata / Doença de Fabry / Doenças da Túnica Conjuntiva Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article